{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:18:39Z","timestamp":1789532319793,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00284-024-03658-0","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T15:02:46Z","timestamp":1712070166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development, Strategies, and Challenges for Tularemia Vaccine"],"prefix":"10.1007","volume":"81","author":[{"given":"Safoura","family":"Moradkasani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Salek","family":"Farrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saber","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"3658_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-812026-2.00001-3","volume-title":"Handbook on biological warfare preparedness","author":"S Flora","year":"2020","unstructured":"Flora S (2020) Biological warfare agents: history and modern-day relevance. Handbook on biological warfare preparedness. Elsevier, Amsterdam, pp 1\u201311. https:\/\/doi.org\/10.1016\/B978-0-12-812026-2.00001-3"},{"key":"3658_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/vdt.S85545","volume":"6","author":"R Sunagar","year":"2016","unstructured":"Sunagar R et al (2016) Tularemia vaccine development: paralysis or progress? Vaccine (Auckl) 6:9\u201323. https:\/\/doi.org\/10.2147\/vdt.S85545","journal-title":"Vaccine (Auckl)"},{"issue":"4","key":"3658_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/B978-0-12-812026-2.00001-3","volume":"87","author":"PC Oyston","year":"2005","unstructured":"Oyston PC, Quarry JE (2005) Tularemia vaccine: past, present and future. Antonie Van Leeuwenhoek 87(4):277\u2013281. https:\/\/doi.org\/10.1016\/B978-0-12-812026-2.00001-3","journal-title":"Antonie Van Leeuwenhoek"},{"key":"3658_CR4","doi-asserted-by":"publisher","first-page":"1348323","DOI":"10.3389\/fmicb.2023.1348323","volume":"14","author":"M Maurin","year":"2024","unstructured":"Maurin M et al (2024) Tularemia treatment: experimental and clinical data. Front Microbiol 14:1348323. https:\/\/doi.org\/10.3389\/fmicb.2023.1348323","journal-title":"Front Microbiol"},{"issue":"1","key":"3658_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1473-3099(15)00355-2","volume":"16","author":"M Maurin","year":"2016","unstructured":"Maurin M, Gyuranecz M (2016) Tularaemia: clinical aspects in Europe. Lancet Infect Dis 16(1):113\u2013124. https:\/\/doi.org\/10.1016\/S1473-3099(15)00355-2","journal-title":"Lancet Infect Dis"},{"key":"3658_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fmicb.2010.00136","volume":"1","author":"JE Br\u00f6ms","year":"2010","unstructured":"Br\u00f6ms JE, Sj\u00f6stedt A, Lavander M (2010) The role of the Francisella tularensis pathogenicity island in type VI secretion, intracellular survival, and modulation of host cell signaling. Front Microbiol 1:136. https:\/\/doi.org\/10.3389\/fmicb.2010.00136","journal-title":"Front Microbiol"},{"issue":"1","key":"3658_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1017\/s0022172400052840","volume":"79","author":"AM Hood","year":"1977","unstructured":"Hood AM (1977) Virulence factors of Francisella tularensis. Epidemiol Infect 79(1):47\u201360. https:\/\/doi.org\/10.1017\/s0022172400052840","journal-title":"Epidemiol Infect"},{"key":"3658_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00065-19","author":"KC Freudenberger Catanzaro","year":"2020","unstructured":"Freudenberger Catanzaro KC, Inzana TJ (2020) The Francisella tularensis polysaccharides: what is the real capsule? Microbiol Mol Biol Rev. https:\/\/doi.org\/10.1128\/mmbr.00065-19","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"3658_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1196\/annals.1409.006","volume":"1105","author":"JS Gunn","year":"2007","unstructured":"Gunn JS, Ernst RK (2007) The structure and function of Francisella lipopolysaccharide. Ann N Y Acad Sci 1105(1):202\u2013218. https:\/\/doi.org\/10.1196\/annals.1409.006","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"3658_CR10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.4161\/hv.10297","volume":"5","author":"EM Barry","year":"2009","unstructured":"Barry EM, Cole LE, Santiago AE (2009) Vaccines against tularemia. Hum Vaccin 5(12):832\u2013838. https:\/\/doi.org\/10.4161\/hv.10297","journal-title":"Hum Vaccin"},{"issue":"13","key":"3658_CR11","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/0264-410x(95)00062-6","volume":"13","author":"M Fulop","year":"1995","unstructured":"Fulop M, Manchee R, Titball R (1995) Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia. Vaccine 13(13):1220\u20131225. https:\/\/doi.org\/10.1016\/0264-410x(95)00062-6","journal-title":"Vaccine"},{"issue":"3","key":"3658_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0882-4010(92)90025-j","volume":"13","author":"A Sj\u00f6stedt","year":"1992","unstructured":"Sj\u00f6stedt A et al (1992) The 17 kDa lipoprotein and encoding gene of Francisella tularensis LVS are conserved in strains of Francisella tularensis. Microb Pathog 13(3):243\u2013249. https:\/\/doi.org\/10.1016\/0882-4010(92)90025-j","journal-title":"Microb Pathog"},{"key":"3658_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.748706","volume":"12","author":"I Pavkova","year":"2021","unstructured":"Pavkova I et al (2021) Francisella tularensis outer membrane vesicles participate in the early phase of interaction with macrophages. Front Microbiol 12:748706. https:\/\/doi.org\/10.3389\/fmicb.2021.748706","journal-title":"Front Microbiol"},{"issue":"1\u20132","key":"3658_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/09687860500042013","volume":"22","author":"IB Holland","year":"2005","unstructured":"Holland IB, Schmitt L, Young J (2005) Type 1 protein secretion in bacteria, the ABC-transporter dependent pathway (review). Mol Membr Biol 22(1\u20132):29\u201339. https:\/\/doi.org\/10.1080\/09687860500042013","journal-title":"Mol Membr Biol"},{"issue":"15","key":"3658_CR15","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1073\/pnas.1114944109","volume":"109","author":"T Eicher","year":"2012","unstructured":"Eicher T et al (2012) Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc Natl Acad Sci U S A 109(15):5687\u20135692. https:\/\/doi.org\/10.1073\/pnas.1114944109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"3658_CR16","doi-asserted-by":"publisher","first-page":"12897","DOI":"10.1073\/pnas.0602582103","volume":"103","author":"H Gil","year":"2006","unstructured":"Gil H et al (2006) Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc Natl Acad Sci U S A 103(34):12897\u201312902. https:\/\/doi.org\/10.1073\/pnas.0602582103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3658_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005463","volume":"4","author":"K Kadzhaev","year":"2009","unstructured":"Kadzhaev K et al (2009) Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model. PLoS ONE 4(5):e5463. https:\/\/doi.org\/10.1371\/journal.pone.0005463","journal-title":"PLoS ONE"},{"key":"3658_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/1471-2180-10-227","volume":"10","author":"AL Forslund","year":"2010","unstructured":"Forslund AL et al (2010) The type IV pilin, PilA, is required for full virulence of Francisella tularensis subspecies tularensis. BMC Microbiol 10:227. https:\/\/doi.org\/10.1186\/1471-2180-10-227","journal-title":"BMC Microbiol"},{"key":"3658_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fcimb.2018.00121","volume":"8","author":"DL Clemens","year":"2018","unstructured":"Clemens DL, Lee BY, Horwitz MA (2018) The Francisella type VI secretion system. Front Cell Infect Microbiol 8:121. https:\/\/doi.org\/10.3389\/fcimb.2018.00121","journal-title":"Front Cell Infect Microbiol"},{"key":"3658_CR20","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2015.0021","author":"M Basler","year":"2015","unstructured":"Basler M (2015) Type VI secretion system: secretion by a contractile nanomachine. Philos Trans R Soc Lond B Biol Sci. https:\/\/doi.org\/10.1098\/rstb.2015.0021","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"3658_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tim.2015.10.005","volume":"24","author":"FR Cianfanelli","year":"2016","unstructured":"Cianfanelli FR, Monlezun L, Coulthurst SJ (2016) Aim, load, fire: the type VI secretion system, a bacterial nanoweapon. Trends Microbiol 24(1):51\u201362. https:\/\/doi.org\/10.1016\/j.tim.2015.10.005","journal-title":"Trends Microbiol"},{"issue":"3","key":"3658_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.chom.2017.02.001","volume":"21","author":"RD Hood","year":"2017","unstructured":"Hood RD, Peterson SB, Mougous JD (2017) From Striking Out to Striking Gold: Discovering that Type VI Secretion Targets Bacteria. Cell Host Microbe 21(3):286\u2013289. https:\/\/doi.org\/10.1016\/j.chom.2017.02.001","journal-title":"Cell Host Microbe"},{"issue":"11","key":"3658_CR23","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1073\/pnas.1524290113","volume":"113","author":"E Del Tordello","year":"2016","unstructured":"Del Tordello E et al (2016) Type VI secretion system sheaths as nanoparticles for antigen display. Proc Natl Acad Sci U S A 113(11):3042\u20133047. https:\/\/doi.org\/10.1073\/pnas.1524290113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3658_CR24","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.130002","volume":"3","author":"J Cuccui","year":"2013","unstructured":"Cuccui J et al (2013) Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis. Open Biol 3(5):130002. https:\/\/doi.org\/10.1098\/rsob.130002","journal-title":"Open Biol"},{"key":"3658_CR25","doi-asserted-by":"publisher","first-page":"15853","DOI":"10.1038\/ncomms15853","volume":"8","author":"M Brodmann","year":"2017","unstructured":"Brodmann M et al (2017) Francisella requires dynamic type VI secretion system and ClpB to deliver effectors for phagosomal escape. Nat Commun 8:15853. https:\/\/doi.org\/10.1038\/ncomms15853","journal-title":"Nat Commun"},{"issue":"13","key":"3658_CR26","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1128\/JB.00198-08","volume":"190","author":"JS Ludu","year":"2008","unstructured":"Ludu JS et al (2008) The Francisella pathogenicity island protein PdpD is required for full virulence and associates with homologues of the type VI secretion system. J Bacteriol 190(13):4584\u20134595. https:\/\/doi.org\/10.1128\/JB.00198-08","journal-title":"J Bacteriol"},{"issue":"11","key":"3658_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2217\/fmb.12.103","volume":"7","author":"E Ramond","year":"2012","unstructured":"Ramond E et al (2012) Proteins involved in Francisella tularensis survival and replication inside macrophages. Future Microbiol 7(11):1255\u20131268. https:\/\/doi.org\/10.2217\/fmb.12.103","journal-title":"Future Microbiol"},{"issue":"1","key":"3658_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.26444\/aaem\/139242","volume":"29","author":"M Wawszczak","year":"2022","unstructured":"Wawszczak M, Banaszczak B, Rastawicki W (2022) Tularaemia\u2014a diagnostic challenge. Ann Agric Environ Med 29(1):12\u201321. https:\/\/doi.org\/10.26444\/aaem\/139242","journal-title":"Ann Agric Environ Med"},{"key":"3658_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fcimb.2017.00122","volume":"7","author":"Y Caspar","year":"2017","unstructured":"Caspar Y, Maurin M (2017) Francisella tularensis susceptibility to antibiotics: a comprehensive review of the data obtained in VITRO and in animal models. Front Cell Infect Microbiol 7:122. https:\/\/doi.org\/10.3389\/fcimb.2017.00122","journal-title":"Front Cell Infect Microbiol"},{"issue":"35","key":"3658_CR30","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/j.vaccine.2013.05.096","volume":"31","author":"ME Marohn","year":"2013","unstructured":"Marohn ME, Barry EM (2013) Live attenuated tularemia vaccines: recent developments and future goals. Vaccine 31(35):3485\u20133491. https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.096","journal-title":"Vaccine"},{"issue":"1","key":"3658_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/infdis\/135.1.55","volume":"135","author":"DS Burke","year":"1977","unstructured":"Burke DS (1977) Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis 135(1):55\u201360. https:\/\/doi.org\/10.1093\/infdis\/135.1.55","journal-title":"J Infect Dis"},{"issue":"36","key":"3658_CR32","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1016\/j.vaccine.2009.06.036","volume":"27","author":"HM El Sahly","year":"2009","unstructured":"El Sahly HM et al (2009) Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine 27(36):4905\u20134911. https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.036","journal-title":"Vaccine"},{"issue":"5","key":"3658_CR33","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1128\/iai.73.5.2644-2654.2005","volume":"73","author":"TH Wu","year":"2005","unstructured":"Wu TH et al (2005) Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect Immun 73(5):2644\u20132654. https:\/\/doi.org\/10.1128\/iai.73.5.2644-2654.2005","journal-title":"Infect Immun"},{"issue":"19","key":"3658_CR34","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.vaccine.2004.10.034","volume":"23","author":"J Wayne Conlan","year":"2005","unstructured":"Wayne Conlan J et al (2005) Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism. Vaccine 23(19):2477\u20132485. https:\/\/doi.org\/10.1016\/j.vaccine.2004.10.034","journal-title":"Vaccine"},{"issue":"3","key":"3658_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1128\/br.30.3.532-538.1966","volume":"30","author":"RB Hornick","year":"1966","unstructured":"Hornick RB, Eigelsbach HT (1966) Aerogenic immunization of man with live tularemia vaccine. Bacteriol Rev 30(3):532\u2013538. https:\/\/doi.org\/10.1128\/br.30.3.532-538.1966","journal-title":"Bacteriol Rev"},{"key":"3658_CR36","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3181\/00379727-108-27049","volume":"108","author":"HT Eigelsbach","year":"1961","unstructured":"Eigelsbach HT et al (1961) Aerogenic immunization of the monkey and guinea pig with live tularemia vaccine. Proc Soc Exp Biol Med 108:732\u2013734. https:\/\/doi.org\/10.3181\/00379727-108-27049","journal-title":"Proc Soc Exp Biol Med"},{"key":"3658_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev.mi.04.100150.001525","volume":"4","author":"L Foshay","year":"1950","unstructured":"Foshay L (1950) Tularemia. Annu Rev Microbiol 4:313\u2013330. https:\/\/doi.org\/10.1146\/annurev.mi.04.100150.001525","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"3658_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4049\/jimmunol.65.4.425","volume":"65","author":"PJ Kadull","year":"1950","unstructured":"Kadull PJ et al (1950) Studies on tularemia V. Immunization of man. J Immunol 65(4):425\u2013435","journal-title":"J Immunol"},{"issue":"10","key":"3658_CR39","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/vaccines10101593","volume":"10","author":"S Rotem","year":"2022","unstructured":"Rotem S et al (2022) A novel approach to vaccine development: concomitant pathogen inactivation and host immune stimulation by peroxynitrite. Vaccines 10(10):1593. https:\/\/doi.org\/10.3390\/vaccines10101593","journal-title":"Vaccines"},{"key":"3658_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/infdis\/114.5.435","volume":"114","author":"M Gordon","year":"1964","unstructured":"Gordon M, Donaldson DM, Wright GG (1964) Immunization of mice with irradiated Pasteurella tularensis. J Infect Dis 114:435\u2013440. https:\/\/doi.org\/10.1093\/infdis\/114.5.435","journal-title":"J Infect Dis"},{"issue":"1","key":"3658_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/erv.10.154","volume":"10","author":"G Mutwiri","year":"2011","unstructured":"Mutwiri G et al (2011) Combination adjuvants: the next generation of adjuvants? Expert Rev Vaccines 10(1):95\u2013107. https:\/\/doi.org\/10.1586\/erv.10.154","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"3658_CR42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1128\/am.17.3.355-359.1969","volume":"17","author":"JE Nutter","year":"1969","unstructured":"Nutter JE (1969) Effect of vaccine, route, and schedule on antibody response of rabbits to Pasteurella tularensis. Appl Microbiol 17(3):355\u2013359. https:\/\/doi.org\/10.1128\/am.17.3.355-359.1969","journal-title":"Appl Microbiol"},{"issue":"11","key":"3658_CR43","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1002\/eji.200737620","volume":"37","author":"CL Lavine","year":"2007","unstructured":"Lavine CL et al (2007) Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity. Eur J Immunol 37(11):3007\u20133020. https:\/\/doi.org\/10.1002\/eji.200737620","journal-title":"Eur J Immunol"},{"issue":"5","key":"3658_CR44","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1128\/iai.01606-06","volume":"75","author":"SD Baron","year":"2007","unstructured":"Baron SD, Singh R, Metzger DW (2007) Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Infect Immun 75(5):2152\u20132162. https:\/\/doi.org\/10.1128\/iai.01606-06","journal-title":"Infect Immun"},{"issue":"2","key":"3658_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.micpath.2007.08.009","volume":"44","author":"JE Eyles","year":"2008","unstructured":"Eyles JE et al (2008) Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS). Microb Pathog 44(2):164\u2013168. https:\/\/doi.org\/10.1016\/j.micpath.2007.08.009","journal-title":"Microb Pathog"},{"issue":"8","key":"3658_CR46","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.4049\/jimmunol.0803242","volume":"182","author":"C Bitsaktsis","year":"2009","unstructured":"Bitsaktsis C et al (2009) Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis. J Immunol 182(8):4899\u20134909. https:\/\/doi.org\/10.4049\/jimmunol.0803242","journal-title":"J Immunol"},{"issue":"8","key":"3658_CR47","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.4049\/jimmunol.180.8.5548","volume":"180","author":"DB Rawool","year":"2008","unstructured":"Rawool DB et al (2008) Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium Francisella tularensis. J Immunol 180(8):5548\u20135557. https:\/\/doi.org\/10.4049\/jimmunol.180.8.5548","journal-title":"J Immunol"},{"issue":"4","key":"3658_CR48","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4049\/jimmunol.87.4.415","volume":"87","author":"HT Eigelsbach","year":"1961","unstructured":"Eigelsbach HT, Downs CM (1961) Prophylactic effectiveness of live and killed tularemia vaccines: I. production of vaccine and evaluation in the white mouse and guinea pig. J Immunol 87(4):415\u2013425","journal-title":"J Immunol"},{"issue":"2","key":"3658_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.micpath.2004.04.005","volume":"37","author":"H Shen","year":"2004","unstructured":"Shen H, Chen W, Conlan JW (2004) Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis. Microb Pathog 37(2):107\u2013110. https:\/\/doi.org\/10.1016\/j.micpath.2004.04.005","journal-title":"Microb Pathog"},{"issue":"1","key":"3658_CR50","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/iai.00978-08","volume":"77","author":"PS Kraemer","year":"2009","unstructured":"Kraemer PS et al (2009) Genome-wide screen in Francisella novicida for genes required for pulmonary and systemic infection in mice. Infect Immun 77(1):232\u2013244. https:\/\/doi.org\/10.1128\/iai.00978-08","journal-title":"Infect Immun"},{"issue":"11","key":"3658_CR51","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.vaccine.2006.11.054","volume":"25","author":"JE Quarry","year":"2007","unstructured":"Quarry JE et al (2007) A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice. Vaccine 25(11):2011\u20132018. https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.054","journal-title":"Vaccine"},{"issue":"9","key":"3658_CR52","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.1128\/iai.00598-06","volume":"74","author":"R Tempel","year":"2006","unstructured":"Tempel R et al (2006) Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect Immun 74(9):5095\u20135105. https:\/\/doi.org\/10.1128\/iai.00598-06","journal-title":"Infect Immun"},{"issue":"7","key":"3658_CR53","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1128\/iai.00351-07","volume":"75","author":"P Mohapatra Nrusingh","year":"2007","unstructured":"Mohapatra Nrusingh P et al (2007) Identification of an orphan response regulator required for the virulence of Francisella spp. and transcription of pathogenicity Island genes. Infect Immun 75(7):3305\u20133314. https:\/\/doi.org\/10.1128\/iai.00351-07","journal-title":"Infect Immun"},{"issue":"4","key":"3658_CR54","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1128\/iai.74.4.2063-2071.2006","volume":"74","author":"MA Pammit","year":"2006","unstructured":"Pammit MA et al (2006) Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Infect Immun 74(4):2063\u20132071. https:\/\/doi.org\/10.1128\/iai.74.4.2063-2071.2006","journal-title":"Infect Immun"},{"issue":"41","key":"3658_CR55","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1016\/j.vaccine.2009.07.034","volume":"27","author":"Y Cong","year":"2009","unstructured":"Cong Y et al (2009) Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge. Vaccine 27(41):5554\u20135561. https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.034","journal-title":"Vaccine"},{"issue":"8","key":"3658_CR56","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1128\/iai.00262-08","volume":"76","author":"NP Mohapatra","year":"2008","unstructured":"Mohapatra NP et al (2008) Combined deletion of four Francisella novicida acid phosphatases attenuates virulence and macrophage vacuolar escape. Infect Immun 76(8):3690\u20133699. https:\/\/doi.org\/10.1128\/iai.00262-08","journal-title":"Infect Immun"},{"issue":"2","key":"3658_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040024","volume":"4","author":"D Kanistanon","year":"2008","unstructured":"Kanistanon D et al (2008) A Francisella mutant in lipid A carbohydrate modification elicits protective immunity. PLoS Pathog 4(2):e24. https:\/\/doi.org\/10.1371\/journal.ppat.0040024","journal-title":"PLoS Pathog"},{"issue":"6","key":"3658_CR58","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1128\/iai.00036-12","volume":"80","author":"S Sanapala","year":"2012","unstructured":"Sanapala S et al (2012) Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida \u0394fopC vaccine strain. Infect Immun 80(6):2177\u20132185. https:\/\/doi.org\/10.1128\/iai.00036-12","journal-title":"Infect Immun"},{"issue":"41","key":"3658_CR59","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1016\/j.vaccine.2008.07.051","volume":"26","author":"CS Bakshi","year":"2008","unstructured":"Bakshi CS et al (2008) An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Vaccine 26(41):5276\u20135288. https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.051","journal-title":"Vaccine"},{"issue":"1","key":"3658_CR60","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1080\/21505594.2022.2132729","volume":"13","author":"P Pavlik","year":"2022","unstructured":"Pavlik P, Spidlova P (2022) Arginine 58 is indispensable for proper function of the Francisella tularensis subsp. holarctica FSC200 HU protein, and its substitution alters virulence and mediates immunity against wild-type strain. Virulence 13(1):1790\u20131809. https:\/\/doi.org\/10.1080\/21505594.2022.2132729","journal-title":"Virulence"},{"issue":"6","key":"3658_CR61","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/j.1365-2958.2008.06139.x","volume":"67","author":"KL Meibom","year":"2008","unstructured":"Meibom KL et al (2008) The heat-shock protein ClpB of Francisella tularensis is involved in stress tolerance and is required for multiplication in target organs of infected mice. Mol Microbiol 67(6):1384\u20131401. https:\/\/doi.org\/10.1111\/j.1365-2958.2008.06139.x","journal-title":"Mol Microbiol"},{"issue":"4","key":"3658_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124326","volume":"10","author":"RV Suresh","year":"2015","unstructured":"Suresh RV et al (2015) Preclinical testing of a vaccine candidate against tularemia. PLoS ONE 10(4):e0124326. https:\/\/doi.org\/10.1371\/journal.pone.0124326","journal-title":"PLoS ONE"},{"key":"3658_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftv058","author":"A Straskova","year":"2015","unstructured":"Straskova A et al (2015) Francisella tularensis type B \u0394dsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivo. Pathog Dis. https:\/\/doi.org\/10.1093\/femspd\/ftv058","journal-title":"Pathog Dis"},{"issue":"5","key":"3658_CR64","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1128\/iai.01789-06","volume":"75","author":"S Sebastian","year":"2007","unstructured":"Sebastian S et al (2007) A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun 75(5):2591\u20132602. https:\/\/doi.org\/10.1128\/iai.01789-06","journal-title":"Infect Immun"},{"issue":"7","key":"3658_CR65","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/infdis\/jir620","volume":"205","author":"TH Kim","year":"2012","unstructured":"Kim TH et al (2012) Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine. J Infect Dis 205(7):1056\u20131065. https:\/\/doi.org\/10.1093\/infdis\/jir620","journal-title":"J Infect Dis"},{"issue":"7","key":"3658_CR66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/dna.2007.0687","volume":"27","author":"WL Sammons-Jackson","year":"2008","unstructured":"Sammons-Jackson WL et al (2008) Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS). DNA Cell Biol 27(7):387\u2013403. https:\/\/doi.org\/10.1089\/dna.2007.0687","journal-title":"DNA Cell Biol"},{"issue":"18","key":"3658_CR67","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/j.vaccine.2009.02.073","volume":"27","author":"AE Santiago","year":"2009","unstructured":"Santiago AE et al (2009) Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes. Vaccine 27(18):2426\u20132436. https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.073","journal-title":"Vaccine"},{"issue":"6","key":"3658_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002487","volume":"3","author":"RD Pechous","year":"2008","unstructured":"Pechous RD et al (2008) A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS ONE 3(6):e2487. https:\/\/doi.org\/10.1371\/journal.pone.0002487","journal-title":"PLoS ONE"},{"issue":"12","key":"3658_CR69","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.1128\/iai.73.12.8345-8352.2005","volume":"73","author":"S Twine","year":"2005","unstructured":"Twine S et al (2005) A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun 73(12):8345\u20138352. https:\/\/doi.org\/10.1128\/iai.73.12.8345-8352.2005","journal-title":"Infect Immun"},{"issue":"1","key":"3658_CR70","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1128\/iai.01241-06","volume":"75","author":"RM Thomas","year":"2007","unstructured":"Thomas RM et al (2007) The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect Immun 75(1):371\u2013378. https:\/\/doi.org\/10.1128\/iai.01241-06","journal-title":"Infect Immun"},{"issue":"1","key":"3658_CR71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1128\/iai.01113-08","volume":"77","author":"A Qin","year":"2009","unstructured":"Qin A et al (2009) Identification of an essential Francisella tularensis subsp. tularensis virulence factor. Infect Immun 77(1):152\u2013161. https:\/\/doi.org\/10.1128\/iai.01113-08","journal-title":"Infect Immun"},{"issue":"1","key":"3658_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/pathogens1010012","volume":"1","author":"SM Twine","year":"2012","unstructured":"Twine SM et al (2012) Roles for wbtC, wbtI, and kdtA genes in lipopolysaccharide biosynthesis, protein glycosylation, virulence, and immunogenicity in Francisella tularensis2 Strain SCHU S4. Pathogens 1(1):12\u201329. https:\/\/doi.org\/10.3390\/pathogens1010012","journal-title":"Pathogens"},{"issue":"5","key":"3658_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037752","volume":"7","author":"D Rockx-Brouwer","year":"2012","unstructured":"Rockx-Brouwer D et al (2012) Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination. PLoS ONE 7(5):e37752. https:\/\/doi.org\/10.1371\/journal.pone.0037752","journal-title":"PLoS ONE"},{"issue":"Pt 11","key":"3658_CR74","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1099\/jmm.0.018911-0","volume":"59","author":"SL Michell","year":"2010","unstructured":"Michell SL et al (2010) Deletion of the Bacillus anthracis capB homologue in Francisella tularensis subspecies tularensis generates an attenuated strain that protects mice against virulent tularaemia. J Med Microbiol 59(Pt 11):1275\u20131284. https:\/\/doi.org\/10.1099\/jmm.0.018911-0","journal-title":"J Med Microbiol"},{"issue":"Pt 11","key":"3658_CR75","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1099\/mic.0.052902-0","volume":"157","author":"PM Ireland","year":"2011","unstructured":"Ireland PM et al (2011) A Francisella tularensis SCHU S4 mutant deficient in \u03b3-glutamyltransferase activity induces protective immunity: characterization of an attenuated vaccine candidate. Microbiology (Reading) 157(Pt 11):3172\u20133179. https:\/\/doi.org\/10.1099\/mic.0.052902-0","journal-title":"Microbiology (Reading)"},{"issue":"5","key":"3658_CR76","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1128\/iai.01498-14","volume":"82","author":"DS Reed","year":"2014","unstructured":"Reed DS et al (2014) Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain. Infect Immun 82(5):2098\u20132105. https:\/\/doi.org\/10.1128\/iai.01498-14","journal-title":"Infect Immun"},{"issue":"1","key":"3658_CR77","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/1348-0421.12555","volume":"62","author":"D Tian","year":"2018","unstructured":"Tian D et al (2018) Evaluation of Francisella tularensis \u0394pdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL\/6J mouse model. Microbiol Immunol 62(1):24\u201333. https:\/\/doi.org\/10.1111\/1348-0421.12555","journal-title":"Microbiol Immunol"},{"issue":"6","key":"3658_CR78","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.micpath.2008.01.003","volume":"44","author":"CA Forestal","year":"2008","unstructured":"Forestal CA et al (2008) A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence. Microb Pathog 44(6):512\u2013523. https:\/\/doi.org\/10.1016\/j.micpath.2008.01.003","journal-title":"Microb Pathog"},{"issue":"6","key":"3658_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130858","volume":"10","author":"S Banik","year":"2015","unstructured":"Banik S et al (2015) Development of a multivalent subunit vaccine against tularemia using tobacco mosaic virus (TMV) based delivery system. PLoS ONE 10(6):e0130858. https:\/\/doi.org\/10.1371\/journal.pone.0130858","journal-title":"PLoS ONE"},{"issue":"3","key":"3658_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259807","volume":"17","author":"KC Freudenberger Catanzaro","year":"2022","unstructured":"Freudenberger Catanzaro KC et al (2022) Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle. PLoS ONE 17(3):e0259807. https:\/\/doi.org\/10.1371\/journal.pone.0259807","journal-title":"PLoS ONE"},{"issue":"31","key":"3658_CR81","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1016\/s0264-410x(01)00189-x","volume":"19","author":"M Fulop","year":"2001","unstructured":"Fulop M et al (2001) Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19(31):4465\u20134472. https:\/\/doi.org\/10.1016\/s0264-410x(01)00189-x","journal-title":"Vaccine"},{"key":"3658_CR82","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1196\/annals.1409.012","volume":"1105","author":"J Wayne Conlan","year":"2007","unstructured":"Wayne Conlan J, Oyston PC (2007) Vaccines against Francisella tularensis. Ann N Y Acad Sci 1105:325\u2013350. https:\/\/doi.org\/10.1196\/annals.1409.012","journal-title":"Ann N Y Acad Sci"},{"issue":"40","key":"3658_CR83","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1016\/j.vaccine.2011.07.075","volume":"29","author":"AJ Hickey","year":"2011","unstructured":"Hickey AJ et al (2011) Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Vaccine 29(40):6941\u20136947. https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.075","journal-title":"Vaccine"},{"issue":"11","key":"3658_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050460","volume":"7","author":"AR Ashtekar","year":"2012","unstructured":"Ashtekar AR et al (2012) A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS. PLoS ONE 7(11):e50460. https:\/\/doi.org\/10.1371\/journal.pone.0050460","journal-title":"PLoS ONE"},{"issue":"2","key":"3658_CR85","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cei.13356","volume":"198","author":"A Abraham","year":"2019","unstructured":"Abraham A et al (2019) A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Clin Exp Immunol 198(2):143\u2013152. https:\/\/doi.org\/10.1111\/cei.13356","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"3658_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200213","volume":"13","author":"AO Whelan","year":"2018","unstructured":"Whelan AO et al (2018) Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles. PLoS ONE 13(10):e0200213. https:\/\/doi.org\/10.1371\/journal.pone.0200213","journal-title":"PLoS ONE"},{"issue":"2","key":"3658_CR87","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1128\/cvi.00738-13","volume":"21","author":"K Richard","year":"2014","unstructured":"Richard K et al (2014) Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain. Clin Vaccine Immunol 21(2):212\u2013226. https:\/\/doi.org\/10.1128\/cvi.00738-13","journal-title":"Clin Vaccine Immunol"},{"key":"3658_CR88","doi-asserted-by":"publisher","first-page":"1195314","DOI":"10.3389\/fcimb.2023.1195314","volume":"13","author":"M Zhao","year":"2023","unstructured":"Zhao M et al (2023) Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines. Front Cell Infect Microbiol 13:1195314. https:\/\/doi.org\/10.3389\/fcimb.2023.1195314","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"3658_CR89","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.vaccine.2008.12.014","volume":"27","author":"Q Jia","year":"2009","unstructured":"Jia Q et al (2009) Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized type A F. tularensis. Vaccine 27(8):1216\u20131229. https:\/\/doi.org\/10.1016\/j.vaccine.2008.12.014","journal-title":"Vaccine"},{"issue":"8","key":"3658_CR90","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1128\/iai.00374-08","volume":"76","author":"JF Huntley","year":"2008","unstructured":"Huntley JF et al (2008) Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis. Infect Immun 76(8):3664\u20133671. https:\/\/doi.org\/10.1128\/iai.00374-08","journal-title":"Infect Immun"},{"issue":"3","key":"3658_CR91","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/cvi.05384-11","volume":"19","author":"R Kaur","year":"2012","unstructured":"Kaur R et al (2012) Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis. Clin Vaccine Immunol 19(3):359\u2013364. https:\/\/doi.org\/10.1128\/cvi.05384-11","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"3658_CR92","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","volume":"239","author":"MA Liu","year":"2011","unstructured":"Liu MA (2011) DNA vaccines: an historical perspective and view to the future. Immunol Rev 239(1):62\u201384. https:\/\/doi.org\/10.1111\/j.1600-065X.2010.00980.x","journal-title":"Immunol Rev"},{"issue":"39","key":"3658_CR93","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1016\/j.vaccine.2009.06.101","volume":"27","author":"SH Gregory","year":"2009","unstructured":"Gregory SH et al (2009) Epitope-based vaccination against pneumonic tularemia. Vaccine 27(39):5299\u20135306. https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.101","journal-title":"Vaccine"},{"issue":"1","key":"3658_CR94","doi-asserted-by":"publisher","first-page":"e85215","DOI":"10.1371\/journal.pone.0085215","volume":"9","author":"S Rotem","year":"2014","unstructured":"Rotem S et al (2014) Protective immunity against lethal F. tularensis holarctica LVS provided by vaccination with selected novel CD8+ T cell epitopes. PLoS ONE 9(1):e85215. https:\/\/doi.org\/10.1371\/journal.pone.0085215","journal-title":"PLoS ONE"},{"issue":"5","key":"3658_CR95","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","volume":"30","author":"GT Szab\u00f3","year":"2022","unstructured":"Szab\u00f3 GT, Mahiny AJ, Vlatkovic I (2022) COVID-19 mRNA vaccines: platforms and current developments. Mol Ther 30(5):1850\u20131868. https:\/\/doi.org\/10.1016\/j.ymthe.2022.02.016","journal-title":"Mol Ther"},{"issue":"4","key":"3658_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009952","volume":"5","author":"HJ Ray","year":"2010","unstructured":"Ray HJ et al (2010) The Fischer 344 rat reflects human susceptibility to francisella pulmonary challenge and provides a new platform for virulence and protection studies. PLoS ONE 5(4):e9952. https:\/\/doi.org\/10.1371\/journal.pone.0009952","journal-title":"PLoS ONE"},{"issue":"3","key":"3658_CR97","doi-asserted-by":"publisher","first-page":"564","DOI":"10.7589\/2015-02-030","volume":"51","author":"VR Brown","year":"2015","unstructured":"Brown VR et al (2015) Pathogenesis and immune responses of Francisella tularensis strains in wild-caught cottontail rabbits (Sylvilagus spp.). J Wildl Dis 51(3):564\u2013575. https:\/\/doi.org\/10.7589\/2015-02-030","journal-title":"J Wildl Dis"},{"issue":"Pt 9","key":"3658_CR98","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1099\/jmm.0.020669-0","volume":"59","author":"M Nelson","year":"2010","unstructured":"Nelson M et al (2010) Characterization of lethal inhalational infection with Francisella tularensis in the common marmoset (Callithrix jacchus). J Med Microbiol 59(Pt 9):1107\u20131113. https:\/\/doi.org\/10.1099\/jmm.0.020669-0","journal-title":"J Med Microbiol"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-024-03658-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-024-03658-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-024-03658-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T08:05:08Z","timestamp":1713773108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-024-03658-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["3658"],"URL":"https:\/\/doi.org\/10.1007\/s00284-024-03658-0","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"13 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"126"}}